Newsletter - Banner

Breadcrumb

Asset Publisher

Canada's Top 40 Research Hospitals

CANADA RESEARCH CHAIRS – FALL 2020

Congratulations to RI-MUHC researchers who received Canada Research Chairs!

  • Shirin Abbasinejad Enger, Canada Research Chair in Medical Physics, CIHR, Tier 2 (New)
  • Stefanie Blain-Moraes, Canada Research Chair in Biosignal Interaction and Personhood Technology, CIHR, Tier 2 (New)
  • David Buckeridge, Canada Research Chair in Population Health Informatics, CIHR, Tier 1 (New)
  • Nada Jabado, Canada Research Chair in Pediatric Oncology, CIHR, Tier 1 (New)
  • Dick Menzies, Canada Research Chair in Tuberculosis Research, CIHR, Tier 1 (New)

We also congratulate two researchers from The Neuro (Montreal Neurological Institute–Hospital) affiliated with the Brain Repair and Integrative Neuroscience (BRaIN) Program at the RI-MUHC:

  • Boris Bernhardt, Canada Research Chair in Cognitive Neuroinformatics of Healthy and Diseased Brains, CIHR, Tier 2 (New)
  • Robert Zatorre, Canada Research Chair in Auditory Cognitive Neuroscience, CIHR, Tier 1 (New)

The Canada Research Chairs Program stands at the centre of a national strategy to make Canada one of the world's top countries in research and development. It invests approximately $295 million per year to attract and retain a diverse cadre of world-class researchers, to reinforce academic research and training excellence in Canadian postsecondary institutions.

Learn more (McGill Newsroom)

—Published Aug. 6, 2020

FALL 2019 CIHR COMPETITION RESULTS

Researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) will be conducting 25 new projects designed to accelerate discoveries of benefit to human health, thanks to the Canadian Institutes of Health Research (CIHR) Fall 2019 Project Grants Competition. The RI-MUHC teams received over $16 million in project funding.

Across Canada, the competition has approved 385 research grants and 4 bridge grants for a total investment of approximately $275 million. In addition, over $7 million was awarded for 74 priority announcement bridge grants.

The CIHR Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

Congratulations to RI-MUHC grant recipients and their teams!

Project Grants

  • Faiz Ahmad Khan, Glenda Sandy, Christopher Fletcher, Neil Andersson
    Community Health Workers in Tuberculosis Prevention & Care Services in Nunavik
  • Carolyn Baglole, Ilan Azuelos
    Prognostic and Therapeutic Utility of Human Antigen R (HuR) in Fibrosis
  • Swneke Bailey
    Investigating the Molecular Determinants of Peritoneal Metastasis from Gastro-Esophageal Adenocarcinomas
  • Geneviève Bernard
    Unraveling the molecular basis of novel forms of hypomyelinating leukodystrophies
  • Nancy Braverman
    Developing retinal gene augmentation therapy for Zellweger Spectrum Disorder
  • Pnina Brodt
    Regulatory circuits controlling the immune microenvironment of liver metastases
  • Stella Daskalopoulou
    Early Prediction of preeclampsia Using arteriaL Stiffness in high-risk prEgnancies; a multinational study (PULSE)
  • Samuel David
    Ferroptosis-mediated damage in Chronic EAE: implications for Progressive MS
  • Maziar Divangahi
    Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection
  • Maziar Divangahi
    Reprogramming HSCs to generate protective trained immunity against TB
  • Julio Fiore Jr
    Opioid versus opioid-free analgesia after surgical discharge: a systematic review and meta-analysis
  • Jacques Genest Jr
    Familial Hypercholesterolemia in Canada: Precision and Personalized Approaches to Increase Identification and Improve Clinical outcomes
  • Wassim Kassouf
    Implication of neutrophil extracellular traps in the efficacy of bladder-sparing therapy in muscle invasive bladder cancer
  • Ivan Litvinov
    Ectopic reactivation of normally silenced germ cell programs contributes to genomic instability, carcinogenesis and cancer progression in Cutaneous T-Cell Lymphomas (CTCL).
  • Monzur Murshed
    Understanding the mechanism of vascular elastocalcinosis and its prevention by MGP
  • Basil Petrof
    Understanding the basis of diaphragmatic weakness in critical illness
  • Giada Sebastiani
    The role of fatty liver in the epidemic of advanced chronic liver disease among people living with HIV
  • Elena Torban
    Actin regulation of ciliogenesis: unraveling novel mechanisms of human ciliopathies caused by mutations in the PCP effector genes
  • Simon Wing
    USP19 in metabolism - mechanisms and translation

Priority announcements

  • Stéphanie Chevalier
    A novel multimodal intervention for surgical prehabilitation of patients with lung cancer
  • Andrey Cybulsky
    Defining the role of ER stress in glomerular disease: identification of new therapeutic and diagnostic targets
  • Maia Kokoeva
    Could mitotic exhaustion of NG2-glia explain the remyelination deficit in MS?
  • Ivan Litvinov
    Prize: Early Career Investigator in Cancer
  • Dan Poenaru
    WeChoose: a mixed-methods study for developing a personalized risk communication tool in pediatric surgery
  • Myriam Srour, Dorothy Barthelemy
    The physiological, molecular and genetic mechanisms underlying lateralization of motor control

Learn more on the Canadian Institutes of Health Research (CIHR) website

—Published January 30, 2020

SPRING 2019 CIHR COMPETITION RESULTS

Researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) will be conducting 15 new projects designed to accelerate discoveries of benefit to human health, thanks to the Canadian Institutes of Health Research (CIHR) Spring 2019 Project Grant competition. The RI-MUHC teams received over $7.5 million in project funding.

Across Canada, the competition has approved 382 research grants and 21 bridge grants for a total investment of approximately $275 million. In addition, almost $1.5 million was awarded for 15 priority announcement bridge grants.

The CIHR Project Grant program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

Congratulations to RI-MUHC grant recipients and their teams!

Project Grants

  • Deborah Da Costa, Francine Demontigny
    Fathers Matter: A Prospective Study to Identify Determinants of Fathers' Engagement During Pregnancy
  • Natalie Dayan, Maria Del Pilar Vélez
    Impact of Infertility and its Treatment on Women's Mental Health
  • Patricia Fontela, Dean Fergusson
    Length of storage of red blood cell units as a risk factor for hospital-acquired infections: an individual patient data meta-analysis
  • Bethany Foster
    Age-dependent sex differences in graft and patient outcomes among solid organ transplant recipients
  • Jacques Genest, Jr.
    Desmocollin 1 (DSC1) and atherosclerosis
  • Ahmad Haidar
    Co-administration of pramlintide and insulin via an automated dual-hormone artificial pancreas system to regulate glucose levels in type 1 diabetes: a 4-week, outpatient, randomized, controlled, crossover trial
  • Monzur Murshed
    Midface hypoplasia caused by cartilage calcification: A mechanistic study with translational implications
  • Cristian O'Flaherty
    Regulation of male fertility by peroxiredoxin 6
  • Sushmita Pamidi, Evelyn Constantin
    Maternal sleep-disordered breathing during pregnancy and long-term health outcomes in children: the 3D pregnancy and birth cohort
  • Constantin Polychronakos
    Driver somatic mutations in autoimmunity
  • Jean-Pierre Routy
    Immunosuppressive pathways and HIV reservoirs in tissues
  • Guillaume Sebire
    Group B Streptococcus-induced placental infection and subsequent sex-dichotomous neurobehavioural impairments in the offspring: Investigating the role of interleukin-1 (IL-1)
  • Tomoko Takano, Ciriaco Piccirillo, Susan Samuel
    Defining the immune dysfunction in childhood nephrotic syndrome: Toward therapeutic reversal without glucocorticoids
  • Evelyne Vinet
    Risk of infections with tumour necrosis factor inhibitors (TNFi) in pregnant women and their offspring


Priority announcements


Learn more on the Canadian Institutes of Health Research (CIHR) website


— Last updated July 15, 2019

See Archive - Funding Results